Page last updated: 2024-09-05

erlotinib hydrochloride and Itching

erlotinib hydrochloride has been researched along with Itching in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (33.33)29.6817
2010's8 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayanoglu, BT; Demirdag, HG; Yalici-Armagan, B1
Kishi, A; Kiyohara, Y; Yamazaki, N1
Del Giudice, P; Delord, JP; Hubiche, T; Roché, H; Sibaud, V; Tournier, E1
Chen, KL; Cho, YT; Chu, CY; Lin, CC; Sheen, YS; Tsai, HE; Yang, CW1
Santini, D; Tonini, G; Vincenzi, B1
Levêque, D1
Buhren, BA; Gerber, PA; Homey, B1
Blanchet, B; Goldwasser, F; Mir, O1
Calarese, P; Morse, L1
Gerdes, S; Mrowietz, U1
Kardaun, SH; van Duinen, KF1
Loffeld, A; Orpin, SD; Talsania, N1

Reviews

2 review(s) available for erlotinib hydrochloride and Itching

ArticleYear
Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer.
    Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:3

    Topics: Acneiform Eruptions; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erlotinib Hydrochloride; Humans; Ichthyosis; Lung Neoplasms; Paronychia; Patient Education as Topic; Pruritus; Quinazolines

2013
EGFR-targeted therapy and related skin toxicity.
    Seminars in oncology nursing, 2006, Volume: 22, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Evidence-Based Medicine; Female; Humans; Ichthyosis; Middle Aged; Neoplasms; Nurse's Role; Oncology Nursing; Practice Guidelines as Topic; Protein Kinase Inhibitors; Pruritus; Quinazolines; Signal Transduction; Skin Care; Trastuzumab

2006

Other Studies

10 other study(ies) available for erlotinib hydrochloride and Itching

ArticleYear
Targeted tumour therapy induced papulopustular rash and other dermatologic side effects: a retrospective study.
    Cutaneous and ocular toxicology, 2019, Volume: 38, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Female; Humans; Lapatinib; Male; Middle Aged; Molecular Targeted Therapy; Panitumumab; Pruritus; Retrospective Studies

2019
Late epidermal growth factor receptor inhibitor-related papulopustular rash: a distinct clinical entity.
    Clinical and experimental dermatology, 2016, Volume: 41, Issue:1

    Topics: Adult; Aged; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pruritus; Quinazolines; Skin Diseases, Papulosquamous; Staphylococcal Infections; Staphylococcus aureus

2016
Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non-Small Cell Lung Cancer.
    JAMA dermatology, 2016, Volume: 152, Issue:3

    Topics: Acneiform Eruptions; Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Compassionate Use Trials; Cross-Sectional Studies; Drug Eruptions; Erlotinib Hydrochloride; Gefitinib; Humans; Ichthyosis; Lung Neoplasms; Paronychia; Pruritus; Quinazolines; Retrospective Studies

2016
Aprepitant for erlotinib-induced pruritus.
    The New England journal of medicine, 2010, Jul-22, Volume: 363, Issue:4

    Topics: Adult; Aged; Aprepitant; Erlotinib Hydrochloride; Female; Humans; Male; Morpholines; Neurokinin-1 Receptor Antagonists; Protein Kinase Inhibitors; Pruritus; Quinazolines

2010
Aprepitant for erlotinib-induced pruritus.
    The New England journal of medicine, 2010, 10-21, Volume: 363, Issue:17

    Topics: Antineoplastic Agents; Aprepitant; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Interactions; Erlotinib Hydrochloride; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Off-Label Use; Protein Kinase Inhibitors; Pruritus; Quinazolines

2010
More on aprepitant for erlotinib-induced pruritus.
    The New England journal of medicine, 2011, 02-03, Volume: 364, Issue:5

    Topics: Antiemetics; Aprepitant; Erlotinib Hydrochloride; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Off-Label Use; Protein Kinase Inhibitors; Pruritus; Quinazolines; Substance P

2011
More on aprepitant for erlotinib-induced pruritus.
    The New England journal of medicine, 2011, 02-03, Volume: 364, Issue:5

    Topics: Adenocarcinoma; Aprepitant; Drug Interactions; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Middle Aged; Morpholines; Neurokinin-1 Receptor Antagonists; Off-Label Use; Protein Kinase Inhibitors; Pruritus; Quinazolines

2011
Follicular rash during therapy with erlotinib (Tarceva).
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2006, Volume: 4, Issue:10

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Facial Dermatoses; Folliculitis; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Pruritus; Quinazolines; Treatment Outcome

2006
Erlotinib-induced florid acneiform rash complicated by extensive impetiginization.
    Clinical and experimental dermatology, 2008, Volume: 33, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Diarrhea; Dose-Response Relationship, Drug; Drug Eruptions; Emollients; Erlotinib Hydrochloride; Humans; Male; Middle Aged; Minocycline; Protein Kinase Inhibitors; Pruritus; Quinazolines

2008
Colloidal oatmeal lotion is an effective treatment for pruritus caused by erlotinib.
    Clinical and experimental dermatology, 2008, Volume: 33, Issue:1

    Topics: Avena; Colloids; Erlotinib Hydrochloride; Humans; Male; Middle Aged; Phytotherapy; Plant Preparations; Protein Kinase Inhibitors; Pruritus; Quinazolines

2008